Related Experiment Video
Updated: Jan 14, 2026

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection
Published on: June 8, 2020
Is Negative Fecal Immunochemical Test Reassuring? The Cumulative Risk of Colorectal Cancer after Multiple Negative
Chi Pang Wen1,2,3, Min Kuang Tsai4, Christopher Wen5
1Institute of Population Health Sciences, National Health Research Institute, Miaoli, Taiwan.
Background/Aims:
Colorectal cancer (CRC) risk is approximately 0.1% according to registry data, and fecal immunochemical tests (FITs) identify approximately 5% of screened individuals as positive. We evaluated whether a negative FIT result is reassuring regarding CRC risk.
Methods:
In this retrospective cohort study, 141,982 Taiwanese individuals aged ≥50 who underwent self-paid medical screening from 1994 to 2008 were enrolled. CRC cases and all-cause deaths were identified through the National Cancer Registry and National Death File. A negative FIT was defined as <20 μg Hb/g.
Results:
There were 987 CRC patients with a negative FIT and 713 with a positive FIT. Among the 133,369 individuals with one negative FIT, 113 CRC patients were registered within 2 years and 803 within 10 years; only 15% of the CRC cases were identified within the first 2 years after testing. The overall incidence was 1.27/1,000 person-years, decreasing by 63% to 0.80/1,000 person-years after one negative FIT. With repeated biennial negative FITs, CRC risk declined to 63%, 53%, 33%, 23%, and 10% over 10 years. All-cause mortality decreased from 1,106/100,000 person-years to 511/100,000 person-years. Notably, 84% of the cohort had consistently negative FIT results across all five rounds.
Conclusions:
Two-thirds of the 10-year CRC risk remained in individuals following one negative FIT. The risk after a negative FIT result reemerged 2 years after testing, highlighting the importance of continuing biennial FIT screening. Consistently negative FITs were associated with reduced CRC risk and a lower all-cause mortality. This study is limited by the lack of confirmatory colonoscopy in FIT-negative individuals, which may lead to an underestimation of CRC incidence.
More Related Videos
Related Concept Videos
Serum Laboratory Studies, Stool Test, Breath Test
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Imaging Studies III: Gastrointestinal Motility Studies and Virtual Colonoscopy
Radionuclide Testing
Radionuclide testing is a sophisticated medical technique for assessing gastrointestinal motility. It focuses on gastric emptying and colonic transit time. Radioactive markers track the movement of food through the digestive system, providing insights into gastrointestinal disorders.
In gastric emptying studies, a meal's liquid and...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

